Ewing Sarcoma: Prognosis, Survival, and Life Expectancy in Childhood Bone Tumors

The Ewing sarcoma is a malignant neoplasm that primarily affects children and adolescents, being the second most common bone tumor in this population. Despite advances in treatment, the prognosis of Ewing sarcoma remains a challenge, particularly in cases with metastatic disease. This article explores the factors influencing Ewing sarcoma survival and current strategies to improve life expectancy in childhood bone tumors.

Factors Influencing Prognosis and Survival

The treatment of Ewing sarcoma requires a multidisciplinary approach that combines chemotherapy, surgery, and radiation therapy. Induction chemotherapy followed by local treatment is the standard; however, the presence of metastasis at diagnosis remains a significant negative prognostic factor. According to a recent study, the five-year survival rate is considerably lower in adolescents and young adults compared to children, suggesting biological or treatment response differences among these age groups.

Local therapy is crucial for disease control. A study from the Ewing 2008 trial showed that patients with a poor response to chemotherapy benefit from the addition of radiation therapy to surgery. Furthermore, consolidative radiation therapy has been shown to improve overall and progression-free survival in patients with metastatic sarcoma.

Conclusions

Despite advancements in the treatment of Ewing sarcoma, Ewing sarcoma survival remains a challenge, especially in cases with metastasis. Ongoing research into targeted therapies and personalized approaches is essential to improve outcomes. Identifying prognostic factors in Ewing and optimizing treatment strategies are fundamental to increasing life expectancy in childhood bone tumors.

References

• [1] Ewing sarcoma
• [2] The survival disparity between children and adolescents and young adults (AYAs) with Ewing sarcoma in the Netherlands did not change since the 1990s despite improved survival: A population-based study
• [3] Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trial
• [4] Impact of Consolidative Radiation on Overall and Progression-Free Survival in Pediatric, Adolescent, and Young Adult Metastatic Bone and Soft Tissue Sarcoma

Created 14/1/2025